Evaluation of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin and irinotecan (FOLFOXIRI) followed by radical surgery of metastases.
Not Applicable
Completed
- Conditions
- Metastatic colorectal cancer treated with FOLFOXIRICancer - Bowel - Back passage (rectum) or large bowel (colon)
- Registration Number
- ACTRN12608000615381
- Lead Sponsor
- Gruppo Oncologico del Nord-Ovest GONO
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 37
Inclusion Criteria
Metastatic colorectal cancer;
Unresectable disease at diagnosis;
First-line treatment with FOLFOXIRI
Exclusion Criteria
Treatment with chemotherapy different from FOLFOXIRI;
Eastern Cooperative Oncology Group (ECOG) Performance status (PS) >2
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method